Revance Therapeutics, Inc. announced that on November 9, 2021, the Board of Directors (the ?Board?) of the Company approved the promotion of Dustin Sjuts, the Company?s Chief Commercial Officer, Aesthetics & Therapeutics, to President, effective as of November 9, 2021 (the ?Effective Date?). In this role, Mr. Sjuts will report to Mark J. Foley, the Chief Executive Officer and principal executive officer of the Company. As President, Mr. Sjuts will oversee all Company operations excluding regulatory, technical operations and general and administrative functions. Mr. Sjuts, age 42, served as the Company?s Chief Commercial Officer, Aesthetics & Therapeutics from December 2019 to November 2021. Mr. Sjuts previously served as the Company?s Head of Commercial, Aesthetics and Therapeutics, from November 2018 to November 2019, and as Vice President, Strategy and Sales from March 2018 to November 2018. Prior to joining the Company, Mr. Sjuts held leadership positions at Nestle Skin Health, including Business Unit Head, China, from January 2017 to April 2018 and Senior Director of Marketing from February 2015 to December 2016. Previously, Mr. Sjuts held positions of increasing responsibility across a range of markets and disciplines with Alphaeon Corporation and Allergan plc, where he was responsible for creating and executing product adoption and sales growth strategies.